USPHNYSEServices-Health ServicesUS GAAP · USD

U.S. Physical Therapy, Inc

U.S. Physical Therapy is a U.S.-based operator of outpatient rehabilitation clinics and industrial injury prevention services. Through its subsidiaries, it provides physical, occupational, and speech therapy, along with onsite employer-focused services such as injury prevention, ergonomic assessments, and functional testing.

Liikevaihto781milj. USD
+16,3 %v/v
Liikevoitto (EBIT)86,7milj. USD
+37,6 %v/v
EBIT-marginaali11,1%
+1,7 %-yks.v/v
Nettotulos39,6milj. USD
+26,0 %v/v
Vapaa kassavirta75,1milj. USD
+0,2 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

0200400600800milj. USD2020: 423 milj. USD2020: EBIT 52 milj. USD20202021: 495 milj. USD2021: EBIT 71 milj. USD20212022: 553 milj. USD2022: EBIT 57 milj. USD20222023: 605 milj. USD2023: EBIT 51 milj. USD20232024: 671 milj. USD2024: EBIT 63 milj. USD20242025: 781 milj. USD2025: EBIT 87 milj. USD202578187
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Physical Therapy Operations85 %

Clinic-based and home-care rehabilitation services for orthopedic, sports, and injury recovery patients.

Industrial Injury Prevention Services15 %

Onsite employer services including injury prevention, testing, rehabilitation, and ergonomic support.

Asiakkaat

The company serves patients referred by physicians, including orthopedic surgeons, neurosurgeons, physiatrists, podiatrists, and primary care doctors. It also serves employers, including Fortune 500 companies, through onsite industrial injury prevention contracts, as well as hospitals, physician groups, insurers, and other healthcare-related referral sources.

Physician-referred patients

Patients referred by orthopedic, neurology, podiatry, and primary care physicians for therapy and rehabilitation.

Employer clients

Companies that contract for onsite injury prevention, rehabilitation, testing, and ergonomic services.

Hospitals and physician groups

Healthcare providers that use management contracts and on-site therapy support.

Insurers and third-party administrators

Buyers of functional testing and related occupational health services tied to claims and return-to-work needs.

Strategia

The company’s strategy is to expand through acquisitions of outpatient therapy practices and home-care businesses, while also adding satellite clinics within existing partnerships. It also seeks to grow its industrial injury prevention platform by acquiring companies that serve employers and related occupational health customers.

Acquire and integrate therapy practicesKeskipitkä aikaväli

Acquisitions expand clinic density, referral reach, and service capacity.

Grow the IIP platformKeskipitkä aikaväli

Employer-facing services diversify revenue beyond patient referrals.

Develop satellite clinicsLyhyt aikaväli

Satellite sites extend the reach of existing partnerships and referral networks.

Maantiede

U.S. Physical Therapy operates primarily in the United States through subsidiaries organized in multiple states. Its business is local in delivery but national in footprint, with clinics and employer-service relationships spread across many markets rather than concentrated in a single region.

Riskit

The business is exposed to Medicare reimbursement changes, complex billing and coding rules, and broader healthcare regulation. It also depends on referral sources and employer contracts that can be terminated with limited notice, while acquisitions, goodwill, and variable-rate debt add execution and financial risk.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Billing and coding compliance1Medicare reimbursement pressure2Contract termination risk3Acquisition and integration risk4Interest rate risk5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Billing and coding complianceVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Therapy reimbursement depends on correct coding and documentation under complex rules.

    KohdistuuCould lead to repayment demandsFinesPenaltiesOr program exclusion
  2. Medicare reimbursement pressureVaikutus: KorkeaTodennäköisyys: Matala

    A large share of patient revenue comes from Medicare, so rate changes affect clinic economics.

    Kohdistuu: Net patient revenue from Medicare was approximately $213.5 million in 2025

  3. Contract termination riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    IIP and management-service customers can end agreements on short notice.

    KohdistuuEmployer clientsHospitalsPhysician groupsAncillary providers
  4. Acquisition and integration riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Growth depends partly on buying and integrating clinics and IIP businesses.

    KohdistuuClinic partnershipsHome-care practicesIIP acquisitions
  5. Interest rate riskVaikutus: KeskitasoTodennäköisyys: Matala

    Outstanding borrowings are variable-rate and the company uses swaps to manage exposure.

    Kohdistuu: Floating-rate debt and derivative counterparties

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition by service line

Different timing for clinic visits, IIP contracts, and prepaid services affects quarterly revenue patterns.

Vaikutus: Clinic services are point-in-time; IIP may be over time based on hours and rates

Goodwill and indefinite-lived intangible impairment

Acquisition-driven growth creates goodwill that must be tested for impairment.

Vaikutus: Write-downs could materially affect earnings and equity

Allowance for credit losses

Patient receivables depend on payor collections and aging by clinic.

Vaikutus: Provision affects operating costs and net receivables

Derivative and hedge accounting

The company uses an interest rate swap to manage variable-rate borrowing exposure.

Vaikutus: Fair value changes can affect earnings or OCI depending on designation

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026

U.S. Physical Therapy, Inc (USPH) liikevaihto, tulos ja tunnusluvut 2025 – Clarifo